Galkin Amends Innovative Eyewear Stake

TL;DR

Galkin updated his stake in Innovative Eyewear. Watch for more details.

AI Summary

Vladimir Galkin filed an amendment to Schedule 13D on September 23, 2024, for Innovative Eyewear Inc. This filing indicates a change in beneficial ownership of the company's common stock. The specific details of the change in ownership, including the number of shares and percentage of ownership, are not fully detailed in the provided text but are the subject of this amendment.

Why It Matters

Changes in beneficial ownership filings like this can signal significant shifts in control or investment strategy by major shareholders, potentially impacting the stock price.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D often indicate significant changes in a major shareholder's position, which can introduce volatility.

Key Players & Entities

• Vladimir Galkin (person) — Filing person and beneficial owner
• Innovative Eyewear Inc (company) — Subject company
• 45791D109 (other) — CUSIP Number for Innovative Eyewear Inc. common stock

FAQ

Key Financial Figures

• $0.00001 — me of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securiti
• $11,156,367 — ted herein. A total of approximately i) $11,156,367 was paid by the Reporting Persons to ac
• $3,563,494 — 481,509 shares of Common Stock; and ii) $3,563,494 was received by the Reporting Persons a

Filing Documents

• vg_sc13dz.htm (SC 13D/A) — 62KB
• 0001376474-24-000538.txt ( ) — 64KB

Security and Issuer

ITEM 1. Security and Issuer This Amendment No. 5 amends the Schedule 13D filed on September 23, 2024 (the "Original Schedule 13D" and, as amended by Amendment No. 1 to Schedule 13D filed on September 23, 2024, and as amended by Amendment No.2 to Schedule 13D filed on September 23, 2024 , and as amended by Amendment No. 3 filed on September 23, 2024, and as amended by Amendment No. 4 filed on September 24, 2024, as amended "the Schedule 13D"). This statement of beneficial ownership on Schedule 13D is jointly filed by each of Vladimir Galkin and Angelica Galkin, husband and wife (collectively, the "Reporting Persons" and individually, a "Reporting Person"), with respect to the shares of the common stock, par value $0.00001 per share (the " Common Stock"), of Innovative Eyewear, Inc., a Florida corporation (the " Issuer") , According to the Issuer, the address of its principal executive office is 1900 Biscayne Blvd., Suite 630, North Miami, Florida 33181. Unless specifically amended hereby, the disclosures set forth in the Original Schedule 13D remain unchanged. Capitalized terms used but not otherwise defined herein have the meanings given to them in the Original Schedule 13D filed on September 23, 2024.

I dentity And Background

ITEM 2. I dentity And Background (a) This Schedule 13D is being filed jointly by each of Vladimir Galkin and Angelica Galkin, husband and wife. (b) The business address of each Reporting Person is 10900 NW 97th Street, #102, Miami, FL 33178. (c) Vladimir Galkin is a citizen of the United States of America, and is principally engaged in the business of: (i) serving as Co-Founder, Executive Chairman, and Manager of HUBX, LLC, a Florida limited liability company; and (ii) investing in securities and real estate. Angelica Galkin is a citizen of the United States of America, and is principally engaged in the business of investing in securities and real estate. (d) No Reporting Person has, during the last five (5) years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) No Reporting Person has, during the last five (5) years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Each of the Reporting Persons is a citizen of the United States of America

Source and Amount of Funds or Other Consideration

ITEM 3. Source and Amount of Funds or Other Consideration . The Reporting Persons used personal funds and margin account borrowings made in the ordinary course of business to make the purchases of shares of Common Stock listed herein. The positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock reported herein. A total of approximately i) $11,156,367 was paid by the Reporting Persons to acquire 1,481,509 shares of Common Stock; and ii) $3,563,494 was received by the Reporting Persons as payment for the sale of 481,509 shares of Common Stock reported herein. Part of the purchase price to acquire such shares of Common Stock was obtained through margin borrowing.

Interest in Securities of the Issuer

ITEM 5. Interest in Securities of the Issuer . (a) As of the date hereof, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own 1,000,000 shares of Common Stock, representing approximately 63.7% of the outstanding shares of Common Stock of Issuer. The foregoing beneficial ownership percentages reported in this Item 5 are based upon 1,570,569 shares of the Issuer's Common Stock outstanding as of August 12, 2024, as reported in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, and filed by the Issuer with the Securities and Exchange Commission (the "SEC") on August 12, 2024. (b) See Rows 7-10 of the cover page for information regarding the power to vote or direct the vote and the power to dispose or direct the disposition of the shares of Common Stock by each of the Reporting Persons. 13D CUSIP No. 45791D109 Page 5 of 7 (c) All the transactions involving shares of Common Stock effected during the past sixty (60) days by any of the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. Except as otherwise noted below, all such transactions were purchases and sales of shares of Common Stock effected in the open market, and the table includes commissions paid in per share prices. (d) On No person other than a Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock beneficially owned by the Reporting Persons. (e) Not Applicable

Material to Be Filed as Exhibits

ITEM 7. Material to Be Filed as Exhibits . 1. Exhibit A - Joint Filing Agreement of the Reporting Persons. 13D CUSIP No. 45791D109 Page 6 of 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: September 25, 2024 By: /s/ Vladimir Galkin Vladimir Galkin Date: September 25, 2024 By: /s/ Angelica Galkin Angelica Galkin 13D CUSIP No. 45791D109 Page 7 of 7 Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Stock of the Issuer which were effectuated by Reporting Persons during the past sixty (60) days. All transactions were effectuated in the open market through a broker. Name of Reporting Person Date of Transactions Type of Transactions Number of Securities Price Per Share (1) Galkin Revocable Trust (2) 09/16/24 Purchase 438,408 $ 5.68 Galkin Revocable Trust (2) 09/16/24 Sale (106,661) $ 6.19 Galkin Revocable Trust (2) 09/17/24 Purchase 346,736 $ 7.12 Galkin Revocable Trust (2) 09/17/24 Sale (258,483) $ 7.27 Galkin Revocable Trust (2) 09/18/24 Purchase 128,130 $ 7.82 Galkin Revocable Trust (2) 09/18/24 Sale (60,000) $ 8.17 Galkin Revocable Trust (2) 09/19/24 Purchase 297,443 $ 8.91 Galkin Revocable Trust (2) 09/19/24 Sale (42,328) $ 9.07 Vladimir and Angelica Galkin 09/20/24 Purchase 70,000 $ 10.31 Vladimir and Angelica Galkin 09/20/24 Sale (14,037) $ 10.61 Vladimir and Angelica Galkin 09/23/24 Purchase 200,792 $ 9.08 (1) The prices reported are volume weighted-average prices and include commissions paid in per share prices. These shares of Common Stock were purchased in multiple transactions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares pu

View Full Filing

View this SC 13D/A filing on SEC EDGAR